Table 2.
Expected Pf | ||||||
---|---|---|---|---|---|---|
Ratio SD/SA | AAAA | AAAD | AADD | ADDD | DDDD | Observed Pf |
0.48 | 98 | 75 | 32 | NS | NS | NS |
0.51 | 102 | 80 | 36 | NS | NS | NS |
0.81 | 91 | 81 | 51 | 14 | NS | 23 ± 6 |
1.46 | 76 | 74 | 60 | 30 | NS | 25 ± 4 |
2.39 | 103 | 102 | 94 | 65 | 18 | 62 ± 9 |
Control: | 8 ± 4 |
From the data in Fig. 5 and Fig. 6, and Table , the expected Pfs (shown in μm/s) were calculated for when zero, one, two, three, or four AQP2-S256D-F monomers per tetramer would be necessary for a plasma membrane localization of AQP2 (AAAA, AAAD, AADD, ADDD, and DDDD, respectively). The observed Pfs ± SEM (shown in μm/s) for the different coinjections and noninjected oocytes (Control) are mean values of at least 12 oocytes. NS, expected and observed Pf values that were not significantly different from noninjected control oocytes. SD, AQP2-S256D-F; SA, AQP2-256A.